Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy

Molecular Therapy(2020)10.1016/j.ymthe.2020.11.026Source: DataRank Database

Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy is a research paper published in Molecular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.38)OA: hybridTopics (53)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Xingli Zhao ORCID,Dongfang Wang ORCID,Dayson Moreira,Yu‐Lin Su ORCID,Marice Alcantara ORCID

Live enrichment

PubMed:33248246 PMC:PMC7934632 OpenAlex:https://openalex.org/W3106905851

NCI NIH HHS

Grant: P30 CA033572

NCI NIH HHS

Grant: R01 CA213131

NCI NIH HHS

Grant: P50 CA107399

National Institutes of Health

FWCI

0.38

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S1525001620306523/pdf

publisherhttp://www.cell.com/article/S1525001620306523/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001620306523?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001620306523?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2020.11.026

Fields of Study

CAR-T cell therapy researchLymphoma Diagnosis and TreatmentToxin Mechanisms and ImmunotoxinsAnimalsApoptosisCell ProliferationHumansLymphoma, B-CellMiceMice, Inbred BALB CMice, Inbred NODMice, SCIDNF-kappa BOligodeoxyribonucleotidesRadiation ToleranceToll-Like Receptor 9Tumor Cells, CulturedXenograft Model Antitumor Assays

MeSH Terms

AnimalsHumansMice, Inbred BALB COligodeoxyribonucleotidesRadiation ToleranceTumor Cells, CulturedNF-kappa BLymphoma, B-CellMice, SCIDMice, Inbred NODApoptosisXenograft Model Antitumor AssaysCell ProliferationToll-Like Receptor 9Mice

Keywords

DecoyIn vivoNF-κBCancer researchLymphomaB-cell lymphomaCancer therapyMedicineBiologyImmunologyCancerInflammationInternal medicineBiotechnologyTLR9Cancer ImmunotherapyRadiation TherapyNon-hodgkin LymphomaDecoy OligodeoxynucleotidesF-κb

Sustainable Development Goals

SDG 0: Good health and well-being